Kellex/Pierpont is an AWE facility from 1943-1983 and a DOE site for 1979-1980 so workers for the AWE years are eligible to file Part B claims and workers for the DOE years are eligible to file both Part B and Part E claims.
Kellex-Pierpont is a Special Exposure Cohort for workers who worked with specific cancers and at least 250 days from January 1, 1943-December 31, 1959.
In 1943, the M.W. Kellogg Company established the Kellex Corporation to design and construct the first gaseous diffusion uranium enrichment facility, the K-25 Plant, in Oak Ridge TN. This work was conducted under contract to the Manhattan Engineer District (MED) and later to the Atomic Energy Commission (AEC). In the 1940s and early 1950s, Kellex conducted research and development on fuel reprocessing and component testing using uranium hexafluoride, and uranium processing and recovery techniques at. In 1951, the Vitro Corporation of America assumed all the rights and obligations of the Kellex Corporation. In 1953, Kellex discontinued all AEC contract work at the Kellex/Pierpont site.
Remediation activities under the Formerly Utilized Site Remediation Action Program (FUSRAP) occurred in 1979 and 1980 by Tobar Construction and Envirosphere Co.. The cleanup was certified in 1983.
During the period of residual contamination, as designated by the National Institute for Occupational Safety and Health and as noted in the dates above, employees of subsequent owners and operators of this facility are also covered under the Energy Employees Occupational Illness Compensation Program Act.
DOE's Legacy Management provides information on Kellex/Pierpont.
DOL provides Part B and Part E statistics on Kellex/Pierpont but no Site Exposure Matrix.
NIOSH provides dose reconstruction statistics for Kellex/Pierpont.
The Wall Street Journal's Waste Lands series provides information on Kellex/Pierpont.